Skip to main content

The non-peptidic macrocyclic antibacterials

  • Chapter
Antibacterial Chemotherapeutic Agents
  • 220 Accesses

Abstract

A large and structurally diverse group of macrocyclic substances exhibit useful anti-infective properties. These compounds are non-peptidic in composition and can be differentiated by general structure and antimicrobial profile. Some substances are principally active against bacteria while others mainly target fungi. The most important antibacterial members contain a characteristic macrocyclic lactone nucleus and are referred to as ‘macrolides’. The macrolides are usually 14-membered or 16-membered lactones adorned with small alkyl groups and oxygen-based functionality (hydroxyl, alkyloxy and ketone groups); all antibacterially active congeners have sugar unit(s) extending from the macrocycle. The macrolides are constructed by soil microorganisms and many of these natural products are valuable chemotherapeutic agents. In addition, a number of semi-synthetic derivatives have also reached the market. The antifungal agents are inherently different from the macrolides and other macrocyclic antibacterials, and will only be mentioned for structural comparison with the antibacterial classes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further reading,Rifamycin antibacterial agents

  • A.J. Bryskier, J.-P. Butzler, H.C. Neu and P.M. Tulkens (Eds) (1993)Macrolides: chemistry, pharmacology and clinical uses Arnette Blackwell, Paris.

    Google Scholar 

  • S. Omura, (Ed.) (1984)Macrolide Antibiotics: Chemistry, Biology and Practice Academic Press, Orlando, FL.

    Google Scholar 

  • H.A. Kirst, J.P. Leeds, J.W. Paschal and J. Martynow (1993) ‘Stereospecific modifications of erythromycin derivatives’, inRecent Advances in the Chemistry of Anti-infective Agents P.H. Bentley and R. Ponsford (Eds), Royal Society of Chemistry, Cambridge, UK, pp. 67–78.

    Google Scholar 

  • H. Kirst(1993) ‘Semi-synthetic derivatives of erythromycin’, inProgress in Medicinal Chemistry Vol. 30, CP. Ellis and D.K. Luscombe (Eds), Elsevier Science, pp. 57–88.

    Google Scholar 

  • H. Kirst(1993) ‘Semi-synthetic derivatives of erythromycin’, inProgress in Medicinal Chemistry Vol. 30, CP. Ellis and D.K. Luscombe (Eds),Elsevier Science, pp. 57–88.

    Google Scholar 

  • H. Kirst and G.D. Sides (1989) ‘New directions for macrolide antibiotics: structural modifications and in vitro activity’,Antimicrob. Agents Chemother. 33, 1413.

    CAS  Google Scholar 

  • H. Kirst and G.D. Sides (1989) ‘New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy’,Antimicrob. Agents Chemother. 33, 1419.

    CAS  Google Scholar 

  • R. Leclercq and P. Courvalin (1991) ‘Bacterial resistance to macrolide, lincosamide and streptogramin antibiotics by target modification’,Antimicrob. Agents Chemother. 35, 1267.

    CAS  Google Scholar 

  • F.J. Antosz (1992) ‘Macrolides’ (Antibiotics), inKirk-Othmer Encyclopedia of Chemical Technology 4th edn, John Wiley, New York, pp. 926–961.

    Google Scholar 

  • D. Vazquez (1975) ‘The macrolide antibiotics’, inAntibiotics III, Mechanism of Action of Antimicrobial and Antitumor Agents J.W. Corcoran and F.E. Hahn (Eds), Springer-Verlag, New York, pp. 459–479.

    Google Scholar 

  • D. Vazquez (1967) ‘Macrolide antibiotics-spiramycin, carbomycin, angolamycin, methymycin and lancamycin’, inAntibiotics I, Mechanism of Action D. Gottlieb and P.D. Shaw (Eds), Springer-Verlag, New York, pp. 366–377.

    Google Scholar 

  • F.E. Hahn (1967) ‘Erythromycin and oleandomycin’, inAntibiotics I, Mechanism of Action D. Gottlieb and P.D. Shaw (Eds), Springer-Verlag, New York, pp. 378–386.

    Google Scholar 

  • N.L. Oleinick (1967) ‘The erythromycins’, inAntibiotics I, Mechanism of ActionD. Gottlieb and P.D. Shaw (Eds), Springer-Verlag, New York, pp. 396–419.

    Google Scholar 

  • E.E. Schmid(1971) ‘The macrolide group of antibiotics’, inAntibiotics and Chemotherapy Vol. 17, Karger, Basel, pp. 52–66.

    Google Scholar 

  • R.K. Boeckman, Jr. and S.W. Goldstein (1988) ‘The total synthesis of macrocyclic lactones’, inThe Total Synthesis of Natural Products Vol. 7, J. ApSimon (Ed.), John Wiley, New York, pp. 1–140.

    Google Scholar 

  • S. Masamune (1978) ‘Recent progress in macrolide synthesis’,Aldrichimica Acta 11, 23.

    CAS  Google Scholar 

  • S. Masamune, G.S. Bates and J.W. Corcoran (1977) ‘Macrolides. Recent progress in chemistry and biochemistry’,Angew. Chem. Int. Ed. Engl. 16, 585.

    Article  CAS  Google Scholar 

  • T.G. Back,(1977) ‘The synthesis of macrocyclic lactones, approaches to complex macrolide antibiotics’,Tetrahedron(Report 46), 33, 3041.

    Google Scholar 

  • K.C. Nicolaou(1977) ‘Synthesis of macrolides’,Tetrahedron(Report 27), 33, 683.

    Google Scholar 

  • R.R. Wilkening, R.W. Ratcliffe, G.A. Doss, K.F. Bartizal, A.C. Graham and CM. Herbert (1993) ‘The synthesis of novel 8a—Aza—8a—homoerythromycin derivatives via the Beekman rearrangement of (9Z)-erythromycin A oxime’,Bioorg. Med. Chem. Lett. 3, 1287.

    Article  CAS  Google Scholar 

  • W.D. Celmer(1971) ‘Stereochemical problems in macrolide antibiotics’, inSymposium on Antibiotics S. Rakhit (Ed.), Organic Chemistry Division Section on Medicinal Chemistry in conjunction with The Medicinal Chemistry Division of the Chemical Institute of Canada and the Canadian Society for Microbiologists, pp. 413–453.

    Google Scholar 

Rifamycin antibacterial agents

  • P. Sensi (1983) ‘History of the development of rifampin’,Rev. Infectious Diseases5, Suppl. 3, S402.

    Article  CAS  Google Scholar 

  • G. Lancini and W. Zanichelli (1977) ‘Structure-activity relationships in rifamycins’, inStructure-Activity Relationships among the Semisynthetic AntibioticsD. Perlman (Ed.), Academic Press, New York, pp. 531–600.

    Google Scholar 

  • W. Wehrli and M. Staehelin (1974) ‘Rifamycins and other ansamycins’, inAntibiotics III, Mechanism of Action of Antimicrobial and Antitumor Agents J.W. Corcoran and F.E. Hahn (Eds), Springer-Verlag, Berlin, pp. 252–268.

    Google Scholar 

  • W. Wehrli and M. Staehelin (1971) ‘Actions of the rifamycins’,Bacteriol. Rev.35, 290.

    CAS  Google Scholar 

  • W. Wehrli, F. Knusel, K. Schmid and M. Staehelin (1968) ‘Interaction of rifamycin with bacterial RNA polymerase’,Proc. Nat. Acad. Sei. Biochem.61, 667.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Chapman & Hall

About this chapter

Cite this chapter

Dax, S.L. (1997). The non-peptidic macrocyclic antibacterials. In: Antibacterial Chemotherapeutic Agents. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0097-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-0097-4_6

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6531-3

  • Online ISBN: 978-94-009-0097-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics